Why I would buy and hold Appen and these quality ASX shares

Appen Ltd (ASX:APX) shares are one of three that I think would be great buy and hold investment options…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

a woman

Over the weekend I demonstrated how buy and hold investing can generate significant wealth for investors.

With that in mind, here are three shares which I think have the potential to be market beaters over the next decade, making them great buy and hold options today:

Appen Ltd (ASX: APX)

When I'm looking for buy and hold options I will first look for an industry or market that has strong growth potential and then ultimately a company that has a leading position within it. That said, I believe Appen is a prime example of what a great buy and hold option looks like. It is the global leader in the development of high-quality, human annotated datasets for an artificial intelligence market forecast to grow materially over the next decade.

REA Group Limited (ASX: REA)

Another top buy and hold option could be this property listings company. I believe its market-leading position in Australia with the realestate.com.au website and its fast-growing international operations have put REA Group in a position to deliver above-average earnings growth once again over the next decade. Furthermore, I believe the fact that the company has continued to achieve strong earnings growth despite the housing market downturn, demonstrates the quality and resilience of its business model.

ResMed Inc (ASX: RMD)

ResMed is a leading developer of products that treat sleep apnea, chronic obstructive pulmonary disease, and other chronic respiratory diseases. According to the company's research, around 1 billion people are estimated to be impacted by sleep apnea worldwide. The vast majority of these people are undiagnosed and at risk of life-threatening conditions such as chronic daytime fatigue, heart disease, stroke, type 2 diabetes, and depression. I expect more and more people to be diagnosed over the next decade, which is likely to lead to increasing demand for its industry-leading products and services.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of Appen Ltd. The Motley Fool Australia has recommended REA Group Limited and ResMed Inc. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

Buy now written on a red key with a shopping trolley on an Apple keyboard.
Growth Shares

2 ASX shares highly recommended to buy: Experts

Multiple analysts rate these business as a buy, here’s why…

Read more »

A young woman uses a laptop and calculator while working from home.
Growth Shares

3 ASX growth shares I'd buy with $7,000

These ASX growth shares are building scalable platforms with room to grow.

Read more »

A couple are happy sitting on their yacht.
Growth Shares

What are the best Australian shares to buy now to try and make a million?

Looking to build wealth over the long-term? These shares could help.

Read more »

Purple tech growth chart.
Growth Shares

2 wonderful ASX All Ords stocks I'd buy today

These stocks could deliver great returns. Here’s why…

Read more »

Cheerful man in a orange shirt standing in front of an audience holding a tablet and using hand gestures to interact with the audience.
Growth Shares

3 amazing ASX growth shares that continue to stand out

Looking for growth options? Here are three to consider.

Read more »

Person pointing finger on on an increasing graph which represents a rising share price.
Growth Shares

2 ASX shares tipped to grow at least 50% in the next 12 months

These stocks could be some of the best ones to own today.

Read more »

Scared looking people on a rollercoaster ride representing volatility.
Growth Shares

What's driving the wild swings in Telix shares?

The ASX biotech stock offers high-growth potential, but it comes with volatility.

Read more »

An executive in a suit smooths his hair and laughs as he looks at his laptop feeling surprised and delighted.
Growth Shares

3 stellar ASX growth shares to buy now with 30% to 70% upside

Analysts have buy ratings and lofty price targets on these shares.

Read more »